Mass Spectrometric Comparison of the Cardiac Globotriaosylceramide Profile in 5 Patients With Fabry's Disease

Circ J. 2022 Dec 23;87(1):154. doi: 10.1253/circj.CJ-22-0607. Epub 2022 Oct 28.

Authors

Kenji Onoue¹, Tomoya Nakano¹, Yasuhiro Akai², Yasuhiro Sakaguchi¹, Yoshihiko Saito¹

Affiliations

¹ Department of Cardiovascular Medicine, Nara Medical University.
² Department of Community-based Medicine, Nara Medical University.

PMID: 36310048
DOI: 10.1253/circj.CJ-22-0607

No abstract available

MeSH terms

Fabry Disease*
Heart
Humans
Kidney
Trihexosylceramides

Substances

globotriaosylceramide
Trihexosylceramides